Hematomorph Session for Part 1 FRCPath Haematology

Поделиться
HTML-код
  • Опубликовано: 3 янв 2025

Комментарии • 2

  • @Audiencecues
    @Audiencecues Месяц назад

    Sorry i have a question.
    Since we monitor response to bypassing agent clinically.
    Why do we need to ch3ck factor viii activity daily? I believe it is for obizur only not for rf7 or feiba.
    Time point 36.06
    Kindly guide what i am missing.
    Thanks!

    • @Hematomorph
      @Hematomorph  Месяц назад

      @@Audiencecues treatment of bleeding and inhibitor eradication starts same day. FVIII activity is monitored as part of inhibitor eradication therapy, not for bypassing agent